日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Whole-body CD8(+) T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

作者更正:CD19靶向CAR T细胞疗法治疗前后大B细胞淋巴瘤患者的全身CD8(+) T细胞PET成像:一项II期研究

de Boer, Janneke W; Keijzer, Kylie; van Doesum, Jaap A; Smit, Nienke A M; Brouwers, Adrienne H; van Sluis, Joyce; Lub-de Hooge, Marjolijn N; Pierik, Frank R; Huls, Gerwin A; van Dijk, Lisanne V; Visser, Lydia; Diepstra, Arjan; Noordzij, Walter; Williams, Simon P; Ungewickell, Alexander; Elias, Sjoerd G; de Vries, Elisabeth G E; Niezink, Anne G H; van Meerten, Tom

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy

急性髓系白血病中维奈托克和低甲基化药物耐药性的驱动因素及提高疗效的策略

Vänttinen, Ida; Saad, Joseph; Ruokoranta, Tanja; Kytölä, Sari; Qin, Guangrong; Tercan, Bahar; Ettala, Pia; Partanen, Anu; Pyörälä, Marja; Rimpiläinen, Johanna; Siitonen, Timo; Manninen, Mikko; Valk, Peter J M; Huls, Gerwin; Thorsson, Vésteinn; Heckman, Caroline A; Kontro, Mika; Kuusanmäki, Heikki

ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia

ΔNp73 亚型定义了急性髓系白血病中一种类似于 TP53 突变体的预后不良亚组。

Diego A Pereira-Martins,Cesar Ortiz,Isabel Weinhäuser,Albertus T J Wierenga,Vincent van den Boom,Fatemeh Mojallali,Dominique Sternadt,Nisha K van der Meer,Shanna M Hogeling,Thiago M Bianco,Prodromos Chatzikyriakou,Douglas R Silveira,Emanuele Ammatuna,Antonio R Lucena-Araujo,Lynn Quek,Gerwin Huls,Eduardo M Rego,Jan Jacob Schuringa

One-Shot SERRS Detection of Iron and Acidity in Aqueous Systems

利用单次SERRS技术检测水溶液中的铁和酸度

Calderón González, Irene; Schuett, Robbert; Chilla, Gerwin; Schulz, Florian; Wang, Zhiming; Parak, Wolfgang J; Alvarez-Puebla, Ramon A

Multi-omic profiling and preclinical efficacy of fratricide-driven, unedited CD7 CAR-T cells in T-cell leukemia

同胞相残驱动的未经编辑的CD7 CAR-T细胞在T细胞白血病中的多组学分析和临床前疗效

Freile, Jimena Álvarez; Rockstein, Lena; Kloosterman, Rianne; Corrales, Macarena González; Visser, Nienke; Lourens, Harm Jan; Frittmann, Orsolya; Dennebos, Robin; Smit, Nienke A M; Setroikomo, Airies; Requesens, Marta; van Rooij, Nienke; Öner, Aysenur; de Bruyn, Marco; van Meerten, Tom; Bellido, Mar; Huls, Gerwin; Gareb, Bahez; Bremer, Edwin

Metformin induces ferroptosis associated with lipidomic remodeling in AML

二甲双胍诱导的铁死亡与急性髓系白血病中的脂质组重塑有关

Sternadt, Dominique; Pereira-Martins, Diego A; Chatzikyriakou, Prodromos; Albuquerque-Simões, Luise; Yang, Ming; Silveira, Douglas R A; Wierenga, Albertus T J; Weinhäuser, Isabel; Hogeling, Shanna M; Oudejans, Lieve L; Casares Alaez, Pilar; Sarry, Jean-Emmanuel; Frezza, Christian; Huls, Gerwin A; Quek, Lynn; Schuringa, Jan Jacob

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

前瞻性随机HOVON-103试验中老年AML患者外部对照患者和内部对照患者的可比性

Hermans, Sjoerd J F; Versluis, Jurjen; van Werkhoven, Erik D; van Norden, Yvette; Janssen, Jeroen J W M; Huls, Gerwin A; Pabst, Thomas; Breems, Dimitri A; Berkx, Elizabeth; Dinmohamed, Avinash G; Huijgens, Peter C; Sträng, Eric; Hernández Rivas, Jesús María; Sobas, Marta; Ayala Diaz, Rosa; Martinez Lopez, Joaquin; Metzeler, Klaus H; Haferlach, Torsten; Thiede, Christian; Uyl-de Groot, Carin A; Bullinger, Lars; Löwenberg, Bob; Ossenkoppele, Gert J; Pignatti, Francesco; Cornelissen, Jan J

Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemia

药物增强阿扎胞苷/维奈托克在急性髓系白血病中的疗效

Westra, Niels; Cerro, Elena Ropero; Schilder, Edwin; Lub-de Hooge, Marjolijn N; Touw, Daan J; Kosterink, Jos G W; Chitu, Dana A; Ammatuna, Emanuele; Klein, Saskia K; Westerweel, Peter E; Cuijpers, Marloes; Cruijsen, Marjan; Corsten, Maarten M F; Alhan, Canan; Tick, Lidwine; Schuringa, Jan Jacob; Huls, Gerwin; Woolthuis, Carolien M; Oude Munnink, Thijs H

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability

高线粒体DNA含量是氧化磷酸化驱动型急性髓系白血病的特征性标志,也是治疗上的一个难点。

Pereira-Martins, Diego A; Weinhäuser, Isabel; Griessinger, Emmanuel; Coelho-Silva, Juan L; Silveira, Douglas R; Sternadt, Dominique; Erdem, Ayşegül; Duarte, Bruno Kosa L; Chatzikyriakou, Prodromos; Quek, Lynn; Alves-Silva, Antonio Bruno; Traina, Fabiola; Olalla Saad, Sara T; Hilberink, Jacobien R; Moreira-Aguiar, Amanda; Salustiano-Bandeira, Maria L; Lima, Marinus M; Franca-Neto, Pedro L; Bezerra, Marcos A; van der Meer, Nisha K; Ammatuna, Emanuele; Rego, Eduardo M; Huls, Gerwin; Schuringa, Jan Jacob; Lucena-Araujo, Antonio R

The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

ENHANCE-3 研究:维奈托克和阿扎胞苷联合马格罗利单抗或安慰剂治疗不适合强化治疗的初治急性髓系白血病

Daver, Naval; Vyas, Paresh; Huls, Gerwin; Döhner, Hartmut; Maury, Sébastien; Novak, Jan; Papayannidis, Cristina; Martínez Chamorro, Carmen; Montesinos, Pau; Niroula, Rabin; Fenaux, Pierre; Esteve, Jordi; Wu, Shang-Ju; De Voeght, Adrien; Mayer, Jiri; Valk, Peter J M; Johnson, Lisa; Dong, Mei; Liu, Ke; Kuwahara, Sowmya; Caldwell, Kenneth; Guru Murthy, Guru Subramanian